Solid tumor

BeiGene is advancing a solid tumor pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. Among these are tislelizumab, a monoclonal antibody against PD-1 and ociperlimap, a monoclonal antibody against TIGIT.
Todos los tipos
Todos los tipos
Lectura
4
Presentación
6
Video
5
Último
Último
latest
Más antiguo
oldest
Todos los tipos
Todos los tipos
Lectura
4
Presentación
6
Video
5
Último
Último
latest
Más antiguo
oldest
Sugerido:
CLL
EHA
ESMO
Hematologic malignancies
Solid tumor
WM
BeiGene
BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene solid tumor pipeline and clinical trials.
Lectura
17 Nov 2023
memo
A summary of the latest developments from 12 studies in the treatment of NSCLC, gastric cancers and other solid tumors presented at ESMO 2022.
Presentación
24 Oct 2022
Cargar más